Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

Clinical trial NCT01527838 · COMPLETED

Trial details

NCT number: NCT01527838
Sponsor: Fate Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma (NHL)Hodgkin's Disease Chronic Lymphocytic Leukemia (CLL)Acute Myelogenous Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)

Start date: 2012-01-01
Primary completion: 2013-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.